Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.

Grisaru D, Hauspy J, Prasad M, Albert M, Murphy KJ, Covens A, Macgregor PF, Rosen B.

Oncol Rep. 2007 Dec;18(6):1347-56.

PMID:
17982616
2.

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.

Bernardini M, Lee CH, Beheshti B, Prasad M, Albert M, Marrano P, Begley H, Shaw P, Covens A, Murphy J, Rosen B, Minkin S, Squire JA, Macgregor PF.

Neoplasia. 2005 Jun;7(6):603-13.

3.

Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells.

Pang E, Hu Y, Chan KY, Lai PB, Squire JA, Macgregor PF, Beheshti B, Albert M, Leung TW, Wong N.

Lab Invest. 2005 May;85(5):664-74.

4.

Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells.

Wong N, Chan KY, Macgregor PF, Lai PB, Squire JA, Beheshti B, Albert M, Leung TW.

Clin Cancer Res. 2005 Feb 1;11(3):1319-26.

5.

Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.

Chan KY, Wong N, Lai PB, Squire JA, Macgregor PF, Beheshti B, Albert M, To KF, Johnson PJ.

Int J Cancer. 2005 May 10;114(6):902-8.

6.

Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes.

Hu Y, Pang E, Lai PB, Squire JA, MacGregor PF, Beheshti B, Albert M, Leung TW, Wong N.

Int J Oncol. 2004 Nov;25(5):1357-64.

PMID:
15492826
7.

Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.

Lightfoot J, Hitzler JK, Zipursky A, Albert M, Macgregor PF.

Leukemia. 2004 Oct;18(10):1617-23.

PMID:
15343346
8.

Using microarrays to predict resistance to chemotherapy in cancer patients.

Lee CH, Macgregor PF.

Pharmacogenomics. 2004 Sep;5(6):611-25. Review.

PMID:
15335284
9.

Gene expression in cancer: the application of microarrays.

Macgregor PF.

Expert Rev Mol Diagn. 2003 Mar;3(2):185-200. Review.

PMID:
12647995
10.

Application of microarrays to the analysis of gene expression in cancer.

Macgregor PF, Squire JA.

Clin Chem. 2002 Aug;48(8):1170-7. Review.

11.

Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA.

Cancer Res. 2002 Jun 15;62(12):3466-76.

12.

Unfolding of microarray data.

Goryachev AB, Macgregor PF, Edwards AM.

J Comput Biol. 2001;8(4):443-61.

PMID:
11571077
13.

Herpes simplex virus triggers and then disarms a host antiviral response.

Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, Smiley JR.

J Virol. 2001 Jan;75(2):750-8.

14.

RNA polymerase II subunit Rpb9 regulates transcription elongation in vivo.

Hemming SA, Jansma DB, Macgregor PF, Goryachev A, Friesen JD, Edwards AM.

J Biol Chem. 2000 Nov 10;275(45):35506-11.

15.

Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.

Macgregor PF, Abate C, Curran T.

Oncogene. 1990 Apr;5(4):451-8.

PMID:
2139203
16.

Inducible proto-oncogene transcription factors: third messengers in the brain?

Curran T, Abate C, Cohen DR, Macgregor PF, Rauscher FJ 3rd, Sonnenberg JL, Connor JA, Morgan JI.

Cold Spring Harb Symp Quant Biol. 1990;55:225-34. Review. No abstract available.

PMID:
2132816

Supplemental Content

Loading ...
Support Center